AIkido Pharma Inc. [NASDAQ: AIKI] plunged by $0.0 during the normal trading session on Thursday and reaching a high of $0.7487 during the day while it closed the day at $0.75. AIkido Pharma Inc. stock has also gained 3.47% of its value over the past 7 days. However, AIKI stock has declined by -53.79% in the 3 months of the year. Over the past six months meanwhile, it has lost -34.51% and lost -42.94% year-on date.
The market cap for AIKI stock reached $25.61 million, with 9.20 million shares outstanding and 32.95 million shares in the current float. Compared to the average trading volume of 4.63M shares, AIKI reached a trading volume of 2639423 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Here’s what leading stock market gurus have to say about AIkido Pharma Inc. [AIKI]:
The Average True Range (ATR) for AIkido Pharma Inc. is set at 0.05, with the Price to Sales ratio for AIKI stock in the period of the last 12 months amounting to 914.75. The Price to Book ratio for the last quarter was 0.33, with the Price to Cash per share for the same quarter was set at 0.48.
AIKI stock trade performance evaluation
AIkido Pharma Inc. [AIKI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.47. With this latest performance, AIKI shares gained by 7.60% in over the last four-week period, additionally sinking by -34.51% over the last 6 months – not to mention a drop of -71.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AIKI stock in for the last two-week period is set at 51.58, with the RSI for the last a single of trading hit 53.65, and the three-weeks RSI is set at 49.83 for AIkido Pharma Inc. [AIKI]. The present Moving Average for the last 50 days of trading for this stock 0.7178, while it was recorded at 0.7567 for the last single week of trading, and 1.2061 for the last 200 days.
AIkido Pharma Inc. [AIKI]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and AIkido Pharma Inc. [AIKI] shares currently have an operating margin of -63166.67. AIkido Pharma Inc.’s Net Margin is presently recorded at -46477.78.
Return on Total Capital for AIKI is now -50.24, given the latest momentum, and Return on Invested Capital for the company is -36.97. Return on Equity for this stock declined to -36.97, with Return on Assets sitting at -34.10.
Reflecting on the efficiency of the workforce at the company, AIkido Pharma Inc. [AIKI] managed to generate an average of -$1,394,333 per employee.AIkido Pharma Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 26.90 and a Current Ratio set at 26.90.
AIkido Pharma Inc. [AIKI]: Insider Ownership positions
There are presently around $0 million, or 0.90% of AIKI stock, in the hands of institutional investors. The top three institutional holders of AIKI stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 210,758, which is approximately 250.248% of the company’s market cap and around 5.64% of the total institutional ownership; TWO SIGMA SECURITIES, LLC, holding 25,694 shares of the stock with an approximate value of $19000.0 in AIKI stocks shares; and SUSQUEHANNA INTERNATIONAL GROUP, LLP, currently with $17000.0 in AIKI stock with ownership of nearly New of the company’s market capitalization.
Positions in AIkido Pharma Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 14 institutional holders increased their position in AIkido Pharma Inc. [NASDAQ:AIKI] by around 244,226 shares. Additionally, 4 investors decreased positions by around 19,415 shares, while 2 investors held positions by with 61,583 shares. The mentioned changes placed institutional holdings at 325,224 shares, according to the latest SEC report filing. AIKI stock had 12 new institutional investments in for a total of 93,150 shares, while 3 institutional investors sold positions of 18,904 shares during the same period.